Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Baird Medical Investment Holdings Limited (BDMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: BDMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -16.77% | Avg. Invested days 41 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 234.17M USD | Price to earnings Ratio 18.4 | 1Y Target Price - |
Price to earnings Ratio 18.4 | 1Y Target Price - | ||
Volume (30-day avg) 76240 | Beta -0.7 | 52 Weeks Range 1.05 - 12.75 | Updated Date 02/26/2025 |
52 Weeks Range 1.05 - 12.75 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.35 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 37.96% | Operating Margin (TTM) 38.74% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 18.4 | Forward PE - | Enterprise Value 248186805 | Price to Sales(TTM) 7.09 |
Enterprise Value 248186805 | Price to Sales(TTM) 7.09 | ||
Enterprise Value to Revenue 7.51 | Enterprise Value to EBITDA 15.25 | Shares Outstanding 36362200 | Shares Floating 10638416 |
Shares Outstanding 36362200 | Shares Floating 10638416 | ||
Percent Insiders 22.16 | Percent Institutions 1.97 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Baird Medical Investment Holdings Limited
Company Overview
History and Background
Baird Medical Investment Holdings Limited is a Chinese company that provides medical device manufacturing and marketing, and medical aesthetic services. It was founded in 2013 and is based in Tianjin, China.
Core Business Areas
- Medical Device Manufacturing and Marketing: Focuses on producing and distributing a variety of medical devices, including vascular intervention devices and respiratory care products. Their products serve hospitals and healthcare facilities globally.
- Medical Aesthetic Services: Offers medical aesthetic procedures and related services in specialized clinics. This segment provides aesthetic solutions to consumers.
Leadership and Structure
Information on the exact leadership team and detailed organizational structure is not readily available in standard financial databases. A deeper dive into company-specific reports would be needed.
Top Products and Market Share
Key Offerings
- Vascular Intervention Devices: These devices are used in minimally invasive procedures to treat vascular diseases. While specific market share data for Baird Medical is not easily accessible, the vascular intervention device market is competitive with larger players like Medtronic (MDT) and Abbott (ABT).
- Respiratory Care Products: Includes devices used for respiratory support and therapy. Market share data is not easily accessible. Competitors in this market include ResMed (RMD) and Fisher & Paykel Healthcare (FSPKF).
- Medical Aesthetic Services: Encompasses various aesthetic procedures. Market share data in this segment is hard to quantify without specific regions, but competitors include Allergan (owned by AbbVie ABBV) and Galderma.
Market Dynamics
Industry Overview
The medical device industry is experiencing growth driven by an aging population, technological advancements, and increased healthcare spending. The medical aesthetics market is also growing significantly due to increasing disposable incomes and a growing desire for non-invasive cosmetic procedures.
Positioning
Baird Medical is positioned as a manufacturer of specialized medical devices targeting specific therapeutic areas. The company also has a presence in the growing medical aesthetics market through their services. Its competitive advantage likely lies in localized market understanding, price competitiveness, and specialized device offerings.
Total Addressable Market (TAM)
The global medical device market is expected to reach hundreds of billions USD in the coming years. The global medical aesthetics market is also projected to reach significant figures. Baird Medical's TAM depends on the specific segments it targets, but the overall potential is substantial. The company's position relative to TAM is smaller, reflecting its size and market share compared to larger global competitors.
Upturn SWOT Analysis
Strengths
- Specialized device offerings
- Medical Aesthetic Clinic
- Price competitiveness in some markets
- Local market knowledge in China
Weaknesses
- Limited brand recognition outside of China
- Smaller scale compared to global medical device giants
- Dependence on the Chinese healthcare market
- Potential regulatory risks in China
Opportunities
- Expansion into new geographic markets
- Development of innovative medical devices
- Strategic partnerships and acquisitions
- Increased demand for medical aesthetics procedures
Threats
- Intense competition from established players
- Changes in healthcare regulations and reimbursement policies
- Economic downturn affecting healthcare spending
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Abbott (ABT)
- ResMed (RMD)
- Allergan (ABBV)
Competitive Landscape
Baird Medical faces significant competition from larger, more established medical device companies. Its competitive advantage likely lies in specific niche markets and localized market knowledge in China. Disadvantages include smaller scale and limited brand recognition in global markets.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth data requires access to the company's financial statements over several years. (Data unavailable for common sources.)
Future Projections: Future growth projections are not readily available without access to analyst reports covering Baird Medical Investment Holdings Limited.
Recent Initiatives: Without specific recent news or reports, current initiatives are unavailable.
Summary
Baird Medical Investment Holdings Limited operates in the growing medical device and aesthetics markets. Its strengths include its specialized offerings and local market knowledge in China. The company faces challenges related to competition and brand recognition in global markets. Growth opportunities exist through geographic expansion and new product development; however, it should watch out for intense market competition and regulations.
Similar Companies
- MDT
- ABT
- RMD
- ABBV
Sources and Disclaimers
Data Sources:
- Yahoo Finance
- Company filings (where available)
- Industry reports (general)
- Market research reports (general)
Disclaimers:
The information provided is based on limited publicly available data. Actual data may vary. This analysis is for informational purposes only and does not constitute financial advice. Market share data are estimations. A financial analyst should be consulted for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Baird Medical Investment Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-10-01 | Chairwoman of the Board of Directors & CEO Ms. Haimei Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 148 | Website https://www.bairdmed.com |
Full time employees 148 | Website https://www.bairdmed.com | ||
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China and the United States. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.